Composition
- Active ingredients
- CLARITHROMYCIN 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CLARITHROMYCIN 187MG/5ML · For suspensionNDA050698-003 · Discontinued
- CLARITHROMYCIN 125MG/5ML · For suspensionNDA050698-001 · Discontinued
- CLARITHROMYCIN 250MG/5ML · For suspensionNDA050698-002 · Discontinued
- CLARITHROMYCIN 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA050662-002 · Discontinued
- CLARITHROMYCIN 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050662.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Biaxin
- Active substance
- clarithromycin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 31 Oct 1991
- Application
- NDA050662-001